Urinary Tract Infections Market Research Report: Market size, Industry outlook, Market Forecast, Demand Analysis,Market Share, Market Report 2018-2023
  • 1-614-588-8538 (Ext: 101)
  • US Toll Free

Urinary Tract Infections Market
Urinary Tract Infections Market: By Drug Type (Penicillin & Combinations, Others); By Test Type (Biochemical, Microscopic, Others); By Indication (Complicated, Recurring, Others); By End-User (Hospitals, Laboratories, Others) & By Region - Forecast(2018 - 2023)
Report Code : HCR 0709
Updated Date: 16 May, 2018  

1. Urinary Tract Infections Market – Overview
2. Executive Summary 
3. Urinary Tract Infections Market Landscape
   3.1. Market Share Analysis
   3.2. Comparative Analysis
   3.3. Product Benchmarking
   3.4. End User Profiling
   3.5. Top 5 Financials Analysis
4. Urinary Tract Infections Market– Forces
   4.1. Drivers
      4.1.1. Development of efficient and advance technology
      4.1.2. Growing prevalence of kidney diseases and urinary tract infections
   4.2. Restraints
      4.2.1. Higher cost of research and development 
   4.3. Opportunities
      4.3.1. Emerging economies
   4.4. Challenges
   4.5. Porter’s Five Forces Analysis
      4.5.1. Bargaining Power of Suppliers
      4.5.2. Bargaining Power of Buyers
      4.5.3. Threat of New Entrants
      4.5.4. Threat of Substitutes
      4.5.5. Degree of Competition
5. Urinary Tract Infections Market– Strategic Analysis
   5.1. Value Chain Analysis
   5.2. Pricing Analysis
   5.3. Opportunities Analysis
   5.4. Product/Market Life Cycle Analysis
   5.5. Suppliers and Distributors
6. Urinary Tract Infections Market, By Drug Type
   6.1. Penicillin & Combinations
   6.2. Quinolones
   6.3. Cephalosporin
   6.4. Aminoglycoside Antibiotics
   6.5. Sulphonamides
   6.6. Azoles and Amphotericin B
   6.7. Tetracycline
   6.8. Nitrofurans
   6.9. Other 
7. Urinary Tract Infections Market, By Test Type
   7.1. Biochemical Urinary Tract Infections 
   7.2. Microscopic  Urinary Tract Infections
   7.3. Flow Cytometric Urinary Tract Infections 
8. Urinary Tract Infections Market, By Indication 
   8.1. Complicated Urinary Tract Infection
   8.2. Recurring Complicated Urinary Tract Infection
   8.3. Uncomplicated Urinary Tract Infection
   8.4. Neurogenic Bladder Infections
9. Urinary Tract Infections Market, By End-User 
   9.1. Hospitals
   9.2. Clinical Laboratories
   9.3. Home Healthcare
   9.4. Research
   9.5. Academics
10. Urinary Tract Infections Market, By Geography
   10.1. Europe
      10.1.1. Germany
      10.1.2. France
      10.1.3. Italy
      10.1.4. Spain
      10.1.5. Russia
      10.1.6. U.K.
      10.1.7. Rest of Europe
   10.2. Asia Pacific
      10.2.1. China
      10.2.2. India
      10.2.3. Japan
      10.2.4. South Korea
      10.2.5. Rest of Asia-Pacific
   10.3. North America 
      10.3.1. U.S.
      10.3.2. Canada
      10.3.3. Mexico
   10.4. Rest of the World (RoW)
      10.4.1. Brazil
      10.4.2. Rest of RoW
11. Urinary Tract Infections – Entropy
   11.1. Expansion
   11.2. Technological Developments
   11.3. Merger & Acquisitions, and Joint Ventures
   11.4. Supply- Contract
12. Company Profiles (Overview, Financials, SWOT Analysis, Developments, Product Portfolio)
   12.1. Mindray Medical International Limited 
   12.2. Urit Medical Electronic Group Co., Ltd.
   12.3. Siemens Healthcare (Subsidiary of Siemens AG) 
   12.4. Roche Diagnostics (A Division of F. Hoffmann-LA Roche Ltd.) 
   12.5. Beckman Coulter, Inc. (Subsidiary of Danaher Corporation)  
   12.6. Sysmex Corporation 
   12.7. Arkray, Inc. 
   12.8. Acon Laboratories, Inc. 
   12.9. Bio-Rad Laboratories, Inc. 
   12.10. Elektronika Kft. 
*More than 40 Companies are profiled in this Research Report, Complete List available on Request*
"*Financials would be provided on a best efforts basis for private companies"
13. Appendix
   13.1. Abbreviations
   13.2. Sources
   13.3. Research Methodology
   13.4. Bibliography
   13.5. Compilation of Expert Insights
   13.6. Disclaimer
Please select Licence
Single User Licence:
US $4250
Corporate User Licence:
US $6250
Related Reports
0px;">Scroll